During the meeting the task force will discuss R4-23-410 Current Good Compounding Practices, and it may make recommendations as to new rules regarding compounding. To see the complete agenda, click here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Showing posts with label Arizona Prescription Compounding Task Force. Show all posts
Showing posts with label Arizona Prescription Compounding Task Force. Show all posts
Wednesday, March 20, 2013
Sunday, January 27, 2013
AZ Prescription Compounding Task Force
Prescription Compounding Task Force
The recent tragedy caused by contaminated compounded
prescription drugs distributed across the country by a pharmacy
in Massachusetts has probably been the “biggest story” in
pharmacy in the last decade. Unfortunately, it is not the kind
of news that pharmacy as a profession is proud of. Any time
a patient suffers a negative outcome is a “failure” both for the
professional involved and for the profession as a whole. In
this extreme case, there were at least 656 cases where patients
were infected by various organisms in the products and 39
deaths in 19 states.
On October 6, NECC [the New England Compounding
Center] expanded its recall to include all products
in circulation that were distributed from its facility in
Framingham, Mass. As part of the ongoing investigation,
FDA [Food and Drug Administration] and CDC
[Centers for Disease Control and Prevention] have
been testing various NECC products for evidence of
contamination. Laboratory testing at CDC and FDA has
found bacterial and/or fungal contamination in unopened
vials of betamethasone, cardioplegia, and triamcinolone
Monday, January 7, 2013
Arizona Board of Pharmacy Prescription Compounding Task Force Comments on NECC
Prescription Compounding Task Force
The recent tragedy caused by contaminated compounded
prescription drugs distributed across the country by a pharmacy
in Massachusetts has probably been the “biggest story” in
pharmacy in the last decade. Unfortunately, it is not the kind
of news that pharmacy as a profession is proud of. Any time
a patient suffers a negative outcome is a “failure” both for the
professional involved and for the profession as a whole. In
this extreme case, there were at least 656 cases where patients
were infected by various organisms in the products and 39
deaths in 19 states.
Continue reading in the Arizona Board of Pharmacy January 2013 Newsletter here
The recent tragedy caused by contaminated compounded
prescription drugs distributed across the country by a pharmacy
in Massachusetts has probably been the “biggest story” in
pharmacy in the last decade. Unfortunately, it is not the kind
of news that pharmacy as a profession is proud of. Any time
a patient suffers a negative outcome is a “failure” both for the
professional involved and for the profession as a whole. In
this extreme case, there were at least 656 cases where patients
were infected by various organisms in the products and 39
deaths in 19 states.
Continue reading in the Arizona Board of Pharmacy January 2013 Newsletter here
Subscribe to:
Posts (Atom)